V. Cervera-Carrascon et al. observed outstanding results, reporting complete remission and survival in a syngeneic mouse model of melanoma treated with an Onc.Ad expressing TNFα and IL-2, with a subsequent anti-PD-1 therapy in a prime and boost manner [69]. The gene discussed is IL2; the disease is melanoma.